But, according to industry experts attending the meeting point of view, the most decisive factor is to accelerate the approval process in Germany  (The same is true in many European countries).From the initial contact with audit institutions to the product, producer than in the United States listed permission to save a lot of time and money.The differences in Medtechinsider also confirmed in a recently completed survey, investigation, said two-thirds of the small medical devices and diagnostics company first is approval of new products in Europe, it is because they like the European regulatory system of predictability.

BVMed conference participants also noticed in November 2010, Stanford university, published a survey.According to the survey, from the initial contact with regulators to the product, in the United States took an average of 54 months, only 11 months in Europe.The registration fee and Europe was also significantly less than the cost of the United States.The meeting also found that 45% of the world's business is beginning from German national medical technology, which is originated in the United States twice the medical technology business.